Analysis Report on China’s Slimming Drug MarketSunFAITH China Ltd.August 26, 2005 8 Pages - SKU: CJFQ1330912 |
| Countries covered: China With the development of living standard, obesity has become the problem people have to face. At present Chinese obesity population is continuously growing larger; the callan obesity problem even stands out. Slimming has become the topic both of the beauty-loving and the fat. There are two major kinds of slimming drug in Chinese market, Western medicine and Chinese patent medicine. The western medicines that Chinese pharmacy companies manufacture are mostly imitations of new drugs that foreign pharmacy companies manufacture due to the weakness of innovation. In TCM slimming market, Chinese pharmacy companies fail to become heavyweight companies or produce heavyweight product, though they produce many kinds of products. Now there is tens-of- billions gap waiting for pharmacy companies to fill up and dig, making the competition even fiercer. Thanks to ‘the favor of TCM” of Chinese consumers, corporations will play a good deal in TCM slimming market. |
More China Pharmaceuticals Reports
Insulin - Top 5 Asian Markets by
Global Research & Data Services
This market research report package offers an in-depth perspective on the actual market situation, trends and future outlook for insulin in top 5 Asian markets. ...
Insulin - China by
Global Research & Data Services
This market research report offers a perspective on the actual market situation, trends and future outlook for insulin in China. The study provides essential market ...
Renal Dialysis Equipment Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018 by
GlobalData
Renal Dialysis Equipment Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018 Summary GlobalData’s new report, “Renal Dialysis Equipment Market Outlook in BRICS (Brazil, ...
China Nephrology and Urology Devices Market Outlook to 2018 - Incontinence Devices, Renal Dialysis Equipment and Lithotripters by
GlobalData
China Nephrology and Urology Devices Market Outlook to 2018 - Incontinence Devices, Renal Dialysis Equipment and Lithotripters Summary GlobalData’s new report, “China Nephrology and Urology Devices Market ...
China's Pharmaceutical Industry 2011 by
China Research and Intelligence Co., Ltd.
This report describes the general development of China’s pharmaceutical industry in aspects of investment, production, sales, import & export, major prices and operations.
...
See all reports like this >>
More China Reports
D&B Country RiskLine Report: China by
Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...
Country Report China February 2011 by
Economist Intelligence Unit
Country Reports analyse political and economic trends in featured countries. They show you exactly how national, regional and global events will affect your business in ...
Country Report China January 2011 by
Economist Intelligence Unit
Country Reports analyse political and economic trends in featured countries. They show you exactly how national, regional and global events will affect your business in ...
D&B Country Report: China by
Dun & Bradstreet Inc.
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...
Wine - BRIC (Brazil, Russia, India, China) Industry Guide by
MarketLine
Datamonitor's Wine - BRIC (Brazil, Russia, India, China) Industry Guide is an essential resource for top-level data and analysis covering the BRIC (Brazil, Russia, India, ...
See all reports like this >>
Related Markets
Pharmaceuticals Reports
- Retinal Vein Occlusion Therapeutics - Pipeline Assessment and Market Forecasts to 2019
- Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q1 2012
- Antibacterials Market to 2017 - Innovative Anti-Infectives that Target MDR Gram-Negative Pathogens Offer Significant Revenue Potential
- Generics in Cardiovascular Diseases Market to 2018 - Loss of Lipitor Market Exclusivities and Impending Patent Expirations of Plavix to Drive Generic Substitution
- Drug Price Cuts in Top Five Countries of Europe - Tougher Reference Pricing Environment and Drug Price Freeze through 2013 Expected to Drive Down Healthcare Costs
